Veru's Enobosarm Shows Muscle In Wegovy Combo Trial

benzinga.com/general/biotech/25/05/45650073/verus-enobosarm-shows-muscle-in-wegovy-combo-trial

Penny stock Veru Inc. (NASDAQ:VERU) on Wednesday released topline safety results from the Phase 2b QUALITY study of enobosarm 3mg, enobosarm 6mg, or placebo to enhance fat loss and prevent muscle loss in patients over 60 years receiving Novo Nordisk A/S’ (NYSE:NVO) Wegovy (semaglutide)…

This story appeared on benzinga.com, 2025-05-28 16:11:21.
The Entire Business World on a Single Page. Free to Use →